PET/CT and the Response to Immunotherapy in Lung Cancer

OBJECTIVE: In recent years, the introduction of immune checkpoint inhibitors has significantly changed the outcome of patients affected by lung cancer and cutaneous melanoma. Although the clinical advantages, the selection of patients and the evaluation of response to immunotherapy remain unclear, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Evangelista, Laura, Sepulcri, Matteo, Pasello, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206188/
https://www.ncbi.nlm.nih.gov/pubmed/31858908
http://dx.doi.org/10.2174/1874471013666191220105449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206188/
https://www.ncbi.nlm.nih.gov/pubmed/31858908
http://dx.doi.org/10.2174/1874471013666191220105449

Ejemplares similares